Skip to main navigation Skip to search Skip to main content

PRE-EMPTIVE GANCICLOVIR THERAPY BASED ON PCR COMPARED WITH PROPHYLAXIS FOR PREVENTION OF CMV DISEASE IN HIGH RISK LIVER TRANSPLANT RECIPIENTS.: Abstract# 1130

  • Michael de Vera
  • , Gregory A. Smallwood
  • , Laurel Davis
  • , Andrie Stieber
  • , Heffron Thomas
  • , Thomas G. Heffron

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalTransplantation
Volume69
DOIs
StatePublished - Apr 1 2000

Disciplines

  • Medicine and Health Sciences
  • Surgery
  • Internal Medicine

Cite this